2014MD Conference ExpressRequires access

Prednisolone but Not PTX Improves 28-Day Mortality in Patients with Alcoholic Hepatitis

Maria Vinall, Mark R. Thursz

Open publisher page 0 citations

Abstract

Severe alcoholic hepatitis, has a 28-day mortality rate of about 35%. Clinical trials have shown both corticosteroids and pentoxifylline (PTX) to be of potential therapeutic benefit, however, both are controversial. This article discusses data from the Steroids or Pentoxifylline for Alcoholic Hepatitis trial [STOPAH; ISRCTN88782125].

About this research paper

What this paper is about

Severe alcoholic hepatitis, has a 28-day mortality rate of about 35%. Clinical trials have shown both corticosteroids and pentoxifylline (PTX) to be of potential therapeutic benefit, however, both are controversial. This article discusses data from the Steroids or Pentoxifylline for Alcoholic Hepatitis trial [STOPAH; ISRCTN88782125].

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Severe alcoholic hepatitis, has a 28-day mortality rate of about 35%. Clinical trials have shown both corticosteroids and pentoxifylline (PTX) to be of potential therapeutic benefit, however, both are controversial. This article discusses data from the Steroids or Pentoxifylline for Alcoholic Hepatitis trial [STOPAH; ISRCTN88782125].

Key concepts: Pentoxifylline, Alcoholic hepatitis, Medicine, Prednisolone, Alcoholic liver disease, Hepatitis, Internal medicine, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
Prednisolone but Not PTX Improves 28-Day Mortality in Patients with Alcoholic Hepatitis — Research Paper | ScholarLens